MUC1 and neoplasm: We incorporated a per-glycosylated MUC1 epitope (GVT*S*APDT*RPAPGS*T*APPAH), whereby all possible glycosylation sites were occupied with TACAs (indicated by asterisks), in order to maximize the potential recognition of glycopeptide tumor-associated epitopes (Wilkinson et al., 2011).